
Biotechnology and Applied Biochemistry (1999) 29, (251261) (Printed in Great Britain)
Accumulation of fibrinogen-coated microparticles at afibrin(ogen)-rich inflammatory site
Ashley P. DeAnglis1, Michael D.Fox and Gregory S. Retzinger
Department of Pathology and Laboratory Medicine, Universityof Cincinnati, Cincinnati, OH 45267-0529, U.S.A.
Abbreviations used: LHF, left hind foot; RHF, right hind foot;
NIH, National Institutes of Health; TDM, trehalose
6,6´-dimycolate; RAI, relative accumulation index.
1 To whom correspondence should be sent.
We have developed methods for coating with fibrinogen both
liposomes and microscopic droplets of olive oil. Because the
fibrinogen bound to them is functional in the classic sense of
fibrin gelation, the coated microparticles may have potential as
vehicles for the targeted delivery of various molecules to sites
of fibrin(ogen) deposition in vivo. So that we could
assess directly this potential, we first established a method for
eliciting reproducibly a focal, fibrin(ogen)-rich, inflammatory
lesion in a hind footpad of mice. We then monitored the tissue
distribution of fibrinogen-coated microparticles following their
injection into the tail vein of mice bearing this well-defined
lesion. As happens with most microparticles following their
intravenous administration, liposomes and oil droplets, whether
coated with fibrinogen or not, accumulate rapidly in the liver
and spleen of treated animals. Indeed, in the case of oil
droplets, accumulation of fibrinogen-coated microparticles in
those organs and in the lungs is even greater than that of
fibrinogen-free microparticles. However, as distinct from
fibrinogen-free liposomes and oil droplets, fibrinogen-coated
microparticles also accumulate in the inflamed hind footpad. We
conclude that fibrinogen-coated liposomes and oil droplets do
have potential as vehicles for delivering molecules to sites of
fibrin(ogen) deposition in vivo.
Received 3 February 1999; accepted 25 February 1999
Portland Press Ltd © 1999
|